Ann: Investor Newsletter, page-3

"We also continue to be on track to move from 1% to 3% of all women screened in the US, approximately 1.2 million, by the end of FY18."
This statement shows the despite very strong sales momentum its literally the tip of the iceberg in evolution terms so VHT has all the makings of a global behemoth as breast density testing moves toward standard procedure.
Nice SP momentum building over the last month or two and a breakout imminent?